The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors

Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell host & microbe 2013-05, Vol.13 (5), p.584-594
Hauptverfasser: Spaan, András N., Henry, Thomas, van Rooijen, Willemien J.M., Perret, Magali, Badiou, Cédric, Aerts, Piet C., Kemmink, Johan, de Haas, Carla J.C., van Kessel, Kok P.M., Vandenesch, François, Lina, Gérard, van Strijp, Jos A.G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 594
container_issue 5
container_start_page 584
container_title Cell host & microbe
container_volume 13
creator Spaan, András N.
Henry, Thomas
van Rooijen, Willemien J.M.
Perret, Magali
Badiou, Cédric
Aerts, Piet C.
Kemmink, Johan
de Haas, Carla J.C.
van Kessel, Kok P.M.
Vandenesch, François
Lina, Gérard
van Strijp, Jos A.G.
description Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identify the human complement receptors C5aR and C5L2 as host targets of PVL, mediating both toxin binding and cytotoxicity. Expression and interspecies variations of the C5aR determine cell and species specificity of PVL. The C5aR binding PVL component, LukS-PV, is a potent inhibitor of C5a-induced immune cell activation. These findings provide insight into leukocidin function and staphylococcal virulence and offer directions for future investigations into individual susceptibility to severe staphylococcal disease. •Staphylococcal Panton-Valentine leukocidin (PVL) targets complement receptors C5aR and C5L2•The C5aR is the major PVL receptor•The PVL component LukS-PV is a potent inhibitor of C5a-induced immune cell activation•C5aR expression levels and interspecies variations determine PVL target specificity
doi_str_mv 10.1016/j.chom.2013.04.006
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00965031v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1931312813001480</els_id><sourcerecordid>1353477557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-5874fbb1ab115fcd2d426136879edeb6859cc7e36ed40229d15fd859800c9453</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhi3UCij0D3CociyHhHH8kUTiglbQrbQSqES9Wo49y3qbxIudoPLv6-1Sjj3NaPzMO9ZDyAWFggKVV9vCbPxQlEBZAbwAkEfklDaM5xJk8-FvT3NGy_qEfIpxCyAEVPSYnJRM1pxBc0oe2g1mj5PebV57b7wxus9a_9uN2YMeJz_mP3WP4-RGzFY4__LG2fTW6vCEU8yW86DHbCF09gMN7iYf4jn5uNZ9xM9v9Yy0d7ftYpmv7r99X9ysciMAplzUFV93HdUdpWJtbGl5KWn6VtWgxU7WojGmQibRcijLxibKpmENYBou2Bm5PMRudK92wQ06vCqvnVrerNR-BtBIAYy-0MR-PbC74J9njJMaXDTY93pEP0dFmWC8qoSoEloeUBN8jAHX79kU1F662qq9dLWXroCnMzItfXnLn7sB7fvKP8sJuD4AmIS8OAwqGoejQesCmklZ7_6X_wcK9pFP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353477557</pqid></control><display><type>article</type><title>The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Spaan, András N. ; Henry, Thomas ; van Rooijen, Willemien J.M. ; Perret, Magali ; Badiou, Cédric ; Aerts, Piet C. ; Kemmink, Johan ; de Haas, Carla J.C. ; van Kessel, Kok P.M. ; Vandenesch, François ; Lina, Gérard ; van Strijp, Jos A.G.</creator><creatorcontrib>Spaan, András N. ; Henry, Thomas ; van Rooijen, Willemien J.M. ; Perret, Magali ; Badiou, Cédric ; Aerts, Piet C. ; Kemmink, Johan ; de Haas, Carla J.C. ; van Kessel, Kok P.M. ; Vandenesch, François ; Lina, Gérard ; van Strijp, Jos A.G.</creatorcontrib><description>Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identify the human complement receptors C5aR and C5L2 as host targets of PVL, mediating both toxin binding and cytotoxicity. Expression and interspecies variations of the C5aR determine cell and species specificity of PVL. The C5aR binding PVL component, LukS-PV, is a potent inhibitor of C5a-induced immune cell activation. These findings provide insight into leukocidin function and staphylococcal virulence and offer directions for future investigations into individual susceptibility to severe staphylococcal disease. •Staphylococcal Panton-Valentine leukocidin (PVL) targets complement receptors C5aR and C5L2•The C5aR is the major PVL receptor•The PVL component LukS-PV is a potent inhibitor of C5a-induced immune cell activation•C5aR expression levels and interspecies variations determine PVL target specificity</description><identifier>ISSN: 1931-3128</identifier><identifier>EISSN: 1934-6069</identifier><identifier>DOI: 10.1016/j.chom.2013.04.006</identifier><identifier>PMID: 23684309</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bacterial Proteins ; Bacterial Proteins - metabolism ; Bacterial Toxins ; Bacterial Toxins - metabolism ; Bacterial Toxins - toxicity ; Cells, Cultured ; Exotoxins ; Exotoxins - metabolism ; Exotoxins - toxicity ; Host-Pathogen Interactions ; Humans ; Leukocidins ; Leukocidins - metabolism ; Leukocidins - toxicity ; Life Sciences ; Receptor, Anaphylatoxin C5a ; Receptor, Anaphylatoxin C5a - metabolism ; Receptors, Chemokine ; Receptors, Chemokine - metabolism ; Staphylococcus aureus ; Staphylococcus aureus - immunology ; Staphylococcus aureus - pathogenicity</subject><ispartof>Cell host &amp; microbe, 2013-05, Vol.13 (5), p.584-594</ispartof><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-5874fbb1ab115fcd2d426136879edeb6859cc7e36ed40229d15fd859800c9453</citedby><cites>FETCH-LOGICAL-c500t-5874fbb1ab115fcd2d426136879edeb6859cc7e36ed40229d15fd859800c9453</cites><orcidid>0000-0002-0687-8565 ; 0000-0001-9412-7106 ; 0000-0002-9236-7998</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.chom.2013.04.006$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23684309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00965031$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Spaan, András N.</creatorcontrib><creatorcontrib>Henry, Thomas</creatorcontrib><creatorcontrib>van Rooijen, Willemien J.M.</creatorcontrib><creatorcontrib>Perret, Magali</creatorcontrib><creatorcontrib>Badiou, Cédric</creatorcontrib><creatorcontrib>Aerts, Piet C.</creatorcontrib><creatorcontrib>Kemmink, Johan</creatorcontrib><creatorcontrib>de Haas, Carla J.C.</creatorcontrib><creatorcontrib>van Kessel, Kok P.M.</creatorcontrib><creatorcontrib>Vandenesch, François</creatorcontrib><creatorcontrib>Lina, Gérard</creatorcontrib><creatorcontrib>van Strijp, Jos A.G.</creatorcontrib><title>The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors</title><title>Cell host &amp; microbe</title><addtitle>Cell Host Microbe</addtitle><description>Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identify the human complement receptors C5aR and C5L2 as host targets of PVL, mediating both toxin binding and cytotoxicity. Expression and interspecies variations of the C5aR determine cell and species specificity of PVL. The C5aR binding PVL component, LukS-PV, is a potent inhibitor of C5a-induced immune cell activation. These findings provide insight into leukocidin function and staphylococcal virulence and offer directions for future investigations into individual susceptibility to severe staphylococcal disease. •Staphylococcal Panton-Valentine leukocidin (PVL) targets complement receptors C5aR and C5L2•The C5aR is the major PVL receptor•The PVL component LukS-PV is a potent inhibitor of C5a-induced immune cell activation•C5aR expression levels and interspecies variations determine PVL target specificity</description><subject>Bacterial Proteins</subject><subject>Bacterial Proteins - metabolism</subject><subject>Bacterial Toxins</subject><subject>Bacterial Toxins - metabolism</subject><subject>Bacterial Toxins - toxicity</subject><subject>Cells, Cultured</subject><subject>Exotoxins</subject><subject>Exotoxins - metabolism</subject><subject>Exotoxins - toxicity</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Leukocidins</subject><subject>Leukocidins - metabolism</subject><subject>Leukocidins - toxicity</subject><subject>Life Sciences</subject><subject>Receptor, Anaphylatoxin C5a</subject><subject>Receptor, Anaphylatoxin C5a - metabolism</subject><subject>Receptors, Chemokine</subject><subject>Receptors, Chemokine - metabolism</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - immunology</subject><subject>Staphylococcus aureus - pathogenicity</subject><issn>1931-3128</issn><issn>1934-6069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhi3UCij0D3CociyHhHH8kUTiglbQrbQSqES9Wo49y3qbxIudoPLv6-1Sjj3NaPzMO9ZDyAWFggKVV9vCbPxQlEBZAbwAkEfklDaM5xJk8-FvT3NGy_qEfIpxCyAEVPSYnJRM1pxBc0oe2g1mj5PebV57b7wxus9a_9uN2YMeJz_mP3WP4-RGzFY4__LG2fTW6vCEU8yW86DHbCF09gMN7iYf4jn5uNZ9xM9v9Yy0d7ftYpmv7r99X9ysciMAplzUFV93HdUdpWJtbGl5KWn6VtWgxU7WojGmQibRcijLxibKpmENYBou2Bm5PMRudK92wQ06vCqvnVrerNR-BtBIAYy-0MR-PbC74J9njJMaXDTY93pEP0dFmWC8qoSoEloeUBN8jAHX79kU1F662qq9dLWXroCnMzItfXnLn7sB7fvKP8sJuD4AmIS8OAwqGoejQesCmklZ7_6X_wcK9pFP</recordid><startdate>20130515</startdate><enddate>20130515</enddate><creator>Spaan, András N.</creator><creator>Henry, Thomas</creator><creator>van Rooijen, Willemien J.M.</creator><creator>Perret, Magali</creator><creator>Badiou, Cédric</creator><creator>Aerts, Piet C.</creator><creator>Kemmink, Johan</creator><creator>de Haas, Carla J.C.</creator><creator>van Kessel, Kok P.M.</creator><creator>Vandenesch, François</creator><creator>Lina, Gérard</creator><creator>van Strijp, Jos A.G.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-0687-8565</orcidid><orcidid>https://orcid.org/0000-0001-9412-7106</orcidid><orcidid>https://orcid.org/0000-0002-9236-7998</orcidid></search><sort><creationdate>20130515</creationdate><title>The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors</title><author>Spaan, András N. ; Henry, Thomas ; van Rooijen, Willemien J.M. ; Perret, Magali ; Badiou, Cédric ; Aerts, Piet C. ; Kemmink, Johan ; de Haas, Carla J.C. ; van Kessel, Kok P.M. ; Vandenesch, François ; Lina, Gérard ; van Strijp, Jos A.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-5874fbb1ab115fcd2d426136879edeb6859cc7e36ed40229d15fd859800c9453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bacterial Proteins</topic><topic>Bacterial Proteins - metabolism</topic><topic>Bacterial Toxins</topic><topic>Bacterial Toxins - metabolism</topic><topic>Bacterial Toxins - toxicity</topic><topic>Cells, Cultured</topic><topic>Exotoxins</topic><topic>Exotoxins - metabolism</topic><topic>Exotoxins - toxicity</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Leukocidins</topic><topic>Leukocidins - metabolism</topic><topic>Leukocidins - toxicity</topic><topic>Life Sciences</topic><topic>Receptor, Anaphylatoxin C5a</topic><topic>Receptor, Anaphylatoxin C5a - metabolism</topic><topic>Receptors, Chemokine</topic><topic>Receptors, Chemokine - metabolism</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - immunology</topic><topic>Staphylococcus aureus - pathogenicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spaan, András N.</creatorcontrib><creatorcontrib>Henry, Thomas</creatorcontrib><creatorcontrib>van Rooijen, Willemien J.M.</creatorcontrib><creatorcontrib>Perret, Magali</creatorcontrib><creatorcontrib>Badiou, Cédric</creatorcontrib><creatorcontrib>Aerts, Piet C.</creatorcontrib><creatorcontrib>Kemmink, Johan</creatorcontrib><creatorcontrib>de Haas, Carla J.C.</creatorcontrib><creatorcontrib>van Kessel, Kok P.M.</creatorcontrib><creatorcontrib>Vandenesch, François</creatorcontrib><creatorcontrib>Lina, Gérard</creatorcontrib><creatorcontrib>van Strijp, Jos A.G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Cell host &amp; microbe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spaan, András N.</au><au>Henry, Thomas</au><au>van Rooijen, Willemien J.M.</au><au>Perret, Magali</au><au>Badiou, Cédric</au><au>Aerts, Piet C.</au><au>Kemmink, Johan</au><au>de Haas, Carla J.C.</au><au>van Kessel, Kok P.M.</au><au>Vandenesch, François</au><au>Lina, Gérard</au><au>van Strijp, Jos A.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors</atitle><jtitle>Cell host &amp; microbe</jtitle><addtitle>Cell Host Microbe</addtitle><date>2013-05-15</date><risdate>2013</risdate><volume>13</volume><issue>5</issue><spage>584</spage><epage>594</epage><pages>584-594</pages><issn>1931-3128</issn><eissn>1934-6069</eissn><abstract>Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identify the human complement receptors C5aR and C5L2 as host targets of PVL, mediating both toxin binding and cytotoxicity. Expression and interspecies variations of the C5aR determine cell and species specificity of PVL. The C5aR binding PVL component, LukS-PV, is a potent inhibitor of C5a-induced immune cell activation. These findings provide insight into leukocidin function and staphylococcal virulence and offer directions for future investigations into individual susceptibility to severe staphylococcal disease. •Staphylococcal Panton-Valentine leukocidin (PVL) targets complement receptors C5aR and C5L2•The C5aR is the major PVL receptor•The PVL component LukS-PV is a potent inhibitor of C5a-induced immune cell activation•C5aR expression levels and interspecies variations determine PVL target specificity</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23684309</pmid><doi>10.1016/j.chom.2013.04.006</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-0687-8565</orcidid><orcidid>https://orcid.org/0000-0001-9412-7106</orcidid><orcidid>https://orcid.org/0000-0002-9236-7998</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1931-3128
ispartof Cell host & microbe, 2013-05, Vol.13 (5), p.584-594
issn 1931-3128
1934-6069
language eng
recordid cdi_hal_primary_oai_HAL_hal_00965031v1
source MEDLINE; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
subjects Bacterial Proteins
Bacterial Proteins - metabolism
Bacterial Toxins
Bacterial Toxins - metabolism
Bacterial Toxins - toxicity
Cells, Cultured
Exotoxins
Exotoxins - metabolism
Exotoxins - toxicity
Host-Pathogen Interactions
Humans
Leukocidins
Leukocidins - metabolism
Leukocidins - toxicity
Life Sciences
Receptor, Anaphylatoxin C5a
Receptor, Anaphylatoxin C5a - metabolism
Receptors, Chemokine
Receptors, Chemokine - metabolism
Staphylococcus aureus
Staphylococcus aureus - immunology
Staphylococcus aureus - pathogenicity
title The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T23%3A08%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Staphylococcal%20Toxin%20Panton-Valentine%20Leukocidin%20Targets%20Human%20C5a%20Receptors&rft.jtitle=Cell%20host%20&%20microbe&rft.au=Spaan,%20Andr%C3%A1s%C2%A0N.&rft.date=2013-05-15&rft.volume=13&rft.issue=5&rft.spage=584&rft.epage=594&rft.pages=584-594&rft.issn=1931-3128&rft.eissn=1934-6069&rft_id=info:doi/10.1016/j.chom.2013.04.006&rft_dat=%3Cproquest_hal_p%3E1353477557%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1353477557&rft_id=info:pmid/23684309&rft_els_id=S1931312813001480&rfr_iscdi=true